Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation.
Rosen
H R
HR
Department of Medicine, Oregon Health Sciences University, Portland 97207, USA.
Benner
K G
KG
Flora
K D
KD
Rabkin
J M
JM
Orloff
S L
SL
Olyaei
A
A
Chou
S
S
D000293:Adolescent; D003587:Cytomegalovirus / Q000187:drug effects / Q000235:genetics; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology / Q000821:virology; D004252:DNA Mutational Analysis; D004352:Drug Resistance, Microbial / Q000235:genetics; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male
D017245:Foscarnet; D015774:Ganciclovir